Zoledronate increases enrichment, activation and expansion of natural killer cells from umbilical cord blood
Authors:
- 13 June 2018
- journal article
- letter
- Published by Springer Nature in Human Cell
- Vol. 31 (4) , 310-312
Abstract
No abstract availableFunding Information
- Natural Science Foundation of Inner Mongolia Autonomous Region (2017MS0314)
This publication has 9 references indexed in Scilit:
- Expansion of Gammadelta T Cells from Cord Blood: A Therapeutical PossibilityStem Cells International, 2018
- Expanded and armed natural killer cells for cancer treatmentCytotherapy, 2016
- Umbilical cord blood–derived cellular products for cancer immunotherapyCytotherapy, 2015
- γδ T Cell Immunotherapy—A ReviewPharmaceuticals, 2015
- Cord blood: a promising source of allogeneic natural killer cells for immunotherapyCytotherapy, 2015
- Differential activation of cord blood and peripheral blood natural killer cells by cytokinesCytotherapy, 2014
- The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activationHuman Immunology, 2012
- Cord Blood Natural Killer Cells Exhibit Impaired Lytic Immunological Synapse Formation That Is Reversed With IL-2 Exvivo ExpansionJournal of Immunotherapy, 2010
- Zoledronate facilitates large-scale ex vivo expansion of functional γδ T cells from cancer patients for use in adoptive immunotherapy*Cytotherapy, 2008